David Kirn, See Remarks at 4D Molecular Therapeutics, Inc. (FDMT), sold 58,333 shares at $12.87 ($737K) on 2026-07-09, disclosed to the SEC on 2026-07-14.
Scheduled sale ($737k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.87 | 42,608 | $548K | 74.3% |
| 2 | $12.01 | 15,283 | $184K | 24.9% |
| 3 | $12.84 | 442 | $6K | 0.8% |
| Total | $12.64 avg | 58,333 | $737K | 100% |
| Filing → |
| FDMT | SELL | 2026-08-21 | $1.1M | — | Filing → |
| FDMT | SELL | 2026-08-05 | $275K | — | Filing → |
| FDMT | SELL | 2026-08-04 | $125K | — | Filing → |